Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy

por Goldman, Jennifer D
Publicado 2018

Cardiovascular safety outcomes of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes

por Goldman, Jennifer D.
Publicado 2020

Commentary: Why Was Inhaled Insulin a Failure in the Market?

por Oleck, Jacob, Kassam, Shahista, Goldman, Jennifer D.
Publicado 2016

Important Factors in Remote Experiential Education

por Prisco, Jennifer L., Goldman, Jennifer D., Eguale, Tewodros, Carace, Nicole
Publicado 2022

Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin

por Goldman, Jennifer D., Angueira-Serrano, Eugenio, Gonzalez, Jeffrey S., Pang, Christianne, Tait, Jacqueline, Edelman, Steven
Publicado 2023

Improved Treatment Engagement Among Patients with Diabetes Treated with Insulin Glargine 300 U/mL Who Participated in the COACH Support Program

por Goldman, Jennifer D., Gill, Jasvinder, Horn, Tony, Reid, Timothy, Strong, Jodi, Polonsky, William H.
Publicado 2018